Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320723 · ClinicalTrials.gov registry record · Phase 4
Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia
A Phase 4 study, sponsored by North Suffolk Mental Health Association.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00320723 is a Phase 4 study that has completed, run by North Suffolk Mental Health Association. The registered enrollment target is 100 participants.
The verdict
NCT00320723, a Phase 4 study, has completed, sponsored by North Suffolk Mental Health Association.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This proposal seeks to evaluate a pilot smoking cessation treatment program that will combine nicotine replacement therapy with or without bupropion sustained-release (SR) with cognitive behavioral therapy for smoking cessation in patients with major mental illness.
Interventions
- DRUG bupropion, transdermal nicotine patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-07 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320723
The ClinicalTrials.gov registry entry for NCT00320723 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Suffolk Mental Health Association, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bupropion, transdermal nicotine patch is the first listed.
NCT00320723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00320723 about?
NCT00320723 is a clinical study titled "Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia". This proposal seeks to evaluate a pilot smoking cessation treatment program that will combine nicotine replacement therapy with or without bupropion sustained-release (SR) with cognitive behavioral therapy for smoking cessation in patients with major mental illness.
What is the current status of trial NCT00320723?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2001-07. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00320723?
The interventions under investigation include: bupropion, transdermal nicotine patch (DRUG).
Who is sponsoring clinical trial NCT00320723?
This trial is sponsored by North Suffolk Mental Health Association, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.